Literature DB >> 12881420

Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40.

Aristides G Eliopoulos1, Chun-Chi Wang, Calin D Dumitru, Philip N Tsichlis.   

Abstract

Macrophages from Tpl2 knockout (Tpl2(-/-)) mice exhibit a defect in ERK activation by lipopolysaccharide (LPS). This impairs the nucleocytoplasmic transport of the tumor necrosis factor alpha (TNF-alpha) mRNA and prevents the induction of TNF-alpha by LPS. As a result, Tpl2(-/-) mice are resistant to LPS/D-galactosamine-induced shock. We demonstrate that Tpl2 is essential for ERK signals transduced by members of the TNF receptor superfamily, such as CD40 and the TNF receptor 1. Thus, ERK activation was impaired in Tpl2(-/-) B cells and macrophages stimulated with agonistic CD40 antibody or TNF-alpha, whereas the induction of other mitogen-activated protein kinases, such as JNK and p38, and the activation of NF-kappaB were unaffected. Tpl2 was recruited to a CD40/TRAF6 complex in response to CD40 stimulation. Moreover, TRAF6, which when overexpressed activates ERK, failed to do so in Tpl2(-/-) cells. The selective signaling defect resulting from the inactivation of Tpl2 allowed us to demonstrate that CD40-mediated ERK activation contributes to immunoglobulin production but is not essential for B-cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12881420      PMCID: PMC169059          DOI: 10.1093/emboj/cdg386

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

1.  CD40-mediated activation of Ig-Cgamma1- and Ig-cepsilon germ-line promoters involves multiple TRAF family proteins.

Authors:  E Leo; J M Zapata; J C Reed
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

2.  CD40 signaling in human dendritic cells is initiated within membrane rafts.

Authors:  P O Vidalain; O Azocar; C Servet-Delprat; C Rabourdin-Combe; D Gerlier; S Manié
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

Review 3.  CD40-CD40 ligand.

Authors:  C van Kooten; J Banchereau
Journal:  J Leukoc Biol       Date:  2000-01       Impact factor: 4.962

Review 4.  Molecular mechanisms of IgE regulation.

Authors:  L B Bacharier; R S Geha
Journal:  J Allergy Clin Immunol       Date:  2000-02       Impact factor: 10.793

5.  CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily.

Authors:  A G Eliopoulos; C Davies; P G Knox; N J Gallagher; S C Afford; D H Adams; L S Young
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

6.  Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways.

Authors:  O J Jupp; S M McFarlane; H M Anderson; A F Littlejohn; A A Mohamed; R H MacKay; P Vandenabeele; D J MacEwan
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

7.  I-kappa B kinase beta is critical for B cell proliferation and antibody response.

Authors:  Hong Ren; Aurelia Schmalstieg; Dorothy Yuan; Richard B Gaynor
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

8.  TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway.

Authors:  C D Dumitru; J D Ceci; C Tsatsanis; D Kontoyiannis; K Stamatakis; J H Lin; C Patriotis; N A Jenkins; N G Copeland; G Kollias; P N Tsichlis
Journal:  Cell       Date:  2000-12-22       Impact factor: 41.582

Review 9.  All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction.

Authors:  Jee Y Chung; Young Chul Park; Hong Ye; Hao Wu
Journal:  J Cell Sci       Date:  2002-02-15       Impact factor: 5.285

10.  CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection.

Authors:  S C Afford; S Randhawa; A G Eliopoulos; S G Hubscher; L S Young; D H Adams
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

View more
  58 in total

Review 1.  Tumor necrosis factor-α signaling in macrophages.

Authors:  Narayanan Parameswaran; Sonika Patial
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

2.  Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide.

Authors:  Jeonghee Cho; Philip N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

3.  Mitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3/7 reinforces the cell response to virus.

Authors:  Sonja Schmid; David Sachs; Benjamin R tenOever
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

Review 4.  How do pleiotropic kinase hubs mediate specific signaling by TNFR superfamily members?

Authors:  Bärbel Schröfelbauer; Alexander Hoffmann
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

5.  Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105.

Authors:  S Beinke; M J Robinson; M Hugunin; S C Ley
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

6.  MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages.

Authors:  Ellen Hebron; Chelsea Hope; Jaehyup Kim; Jeffrey L Jensen; Claire Flanagan; Neehar Bhatia; Ioanna Maroulakou; Constantine Mitsiades; Shigeki Miyamoto; Natalie Callander; Peiman Hematti; Fotis Asimakopoulos
Journal:  Br J Haematol       Date:  2012-12-18       Impact factor: 6.998

7.  Ablation of tumor progression locus 2 promotes a type 2 Th cell response in Ovalbumin-immunized mice.

Authors:  Wendy T Watford; Chun-Chi Wang; Christos Tsatsanis; Lisa A Mielke; Aristides G Eliopoulos; Constantine Daskalakis; Nicolas Charles; Sandra Odom; Juan Rivera; John O'Shea; Philip N Tsichlis
Journal:  J Immunol       Date:  2009-12-02       Impact factor: 5.422

8.  TPL2 kinase is a suppressor of lung carcinogenesis.

Authors:  Katerina Gkirtzimanaki; Kalliopi K Gkouskou; Urszula Oleksiewicz; Georgios Nikolaidis; Dimitra Vyrla; Michalis Liontos; Vassiliki Pelekanou; Dimitris C Kanellis; Kostantinos Evangelou; Efstathios N Stathopoulos; John K Field; Philip N Tsichlis; Vassilis Gorgoulis; Triantafillos Liloglou; Aristides G Eliopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

9.  Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis.

Authors:  Vasiliki Koliaraki; Manolis Roulis; George Kollias
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

10.  Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis.

Authors:  Jennifer Jager; Thierry Grémeaux; Teresa Gonzalez; Stéphanie Bonnafous; Cyrille Debard; Martine Laville; Hubert Vidal; Albert Tran; Philippe Gual; Yannick Le Marchand-Brustel; Mireille Cormont; Jean-François Tanti
Journal:  Diabetes       Date:  2009-10-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.